Company Filing History:
Years Active: 2016
Title: **Xiaodong Cheng: A Pioneer in Epigenetic Transformation**
Introduction
Xiaodong Cheng, based in Decatur, GA, is an innovative inventor known for his significant contributions to the field of epigenetics. With his groundbreaking work, Cheng aims to advance the understanding of cellular transformation and pluripotency, actively shaping the future of biotechnology.
Latest Patents
Cheng holds a patent titled "Compounds and compositions used to epigenetically transform cells and methods related thereto." This patent centers on compounds, compositions, and methods for epigenetically transforming cells. It describes a process of generating epigenetically altered cells by mixing isolated cells with the disclosed compositions under conditions that favor the formation of these altered cells. The invention emphasizes the potential of inducing adult somatic cells or non-pluripotent cells into cells with chemically induced pluripotency. Additionally, the patent discusses various compounds, derivatives, and salts used for these transformative purposes.
Career Highlights
Working at Emory University, Cheng has made significant strides in research, focusing on the intricacies of epigenetic transformations. His role encompasses both innovative research and the development of practical applications that may influence therapeutic strategies in regenerative medicine.
Collaborations
Throughout his career, Xiaodong Cheng has collaborated with esteemed colleagues, including Young-Sup Yoon and Ji Woong Han. Together, they work towards enhancing the understanding of epigenetics and its applications, pushing the boundaries of traditional cell biology.
Conclusion
Xiaodong Cheng's work at Emory University highlights his dedication to advancing epigenetic research. His innovative patent not only underscores his expertise but also offers potential solutions for creating pluripotent cells, which could have far-reaching implications in medicine and biotechnology. With ongoing collaborations and a commitment to research, Cheng is poised to remain a significant figure in the field of epigenetics.